Researchers Submit Patent Application, "Pharmacogenomics Score To Make Decisions On Therapy Augmentation In Aml", for Approval (USPTO 20240344145).

Researchers from the University of Florida Research Foundation Inc. have submitted a patent application for a method that involves characterizing subjects with cancer, particularly leukemia, based on their genotype scores. The method aims to personalize treatment plans by administering cytarabine at tailored dosages according to the subject's genetic makeup. This approach could potentially improve outcomes for individuals with leukemia, including pediatric patients, by optimizing therapy augmentation. The patent application outlines specific SNP locations and genotype scoring methods to guide personalized therapy decisions in acute myeloid leukemia (AML) cases. [Extracted from the article]